Parallel Advisors, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,063
+3.2%
239
+11.2%
0.00%
Q3 2022$2,000
-90.5%
215
-88.7%
0.00%
-100.0%
Q4 2021$21,000
+200.0%
1,899
+109.8%
0.00%
Q3 2021$7,000
+250.0%
905
+472.8%
0.00%
Q2 2021$2,000
-33.3%
1580.0%0.00%
Q1 2021$3,0000.0%1580.0%0.00%
Q4 2020$3,000
+50.0%
1580.0%0.00%
Q3 2020$2,000
-33.3%
1580.0%0.00%
Q2 2020$3,0000.0%1580.0%0.00%
Q1 2020$3,000
-25.0%
1580.0%0.00%
Q4 2019$4,000
+33.3%
1580.0%0.00%
Q3 2019$3,0000.0%1580.0%0.00%
Q2 2019$3,000
-25.0%
1580.0%0.00%
Q1 2019$4,0000.0%1580.0%0.00%
-100.0%
Q4 2018$4,000
-20.0%
1580.0%0.00%0.0%
Q3 2018$5,000
+66.7%
1580.0%0.00%
Q2 2018$3,000
-40.0%
158
-18.1%
0.00%
-100.0%
Q1 2018$5,0000.0%1930.0%0.00%0.0%
Q4 2017$5,0000.0%1930.0%0.00%0.0%
Q3 2017$5,000
-16.7%
1930.0%0.00%0.0%
Q2 2017$6,000
-62.5%
193
-50.0%
0.00%
-50.0%
Q1 2017$16,000
+166.7%
386
+100.0%
0.00%
+100.0%
Q4 2016$6,0001930.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Link Fund Solutions Ltd 5,251,349$135,459,00069.86%
Chescapmanager LLC 949,006$24,570,0003.61%
Baupost Group 9,309,168$241,014,0002.66%
Rock Springs Capital Management LP 655,200$16,963,0000.54%
Rubric Capital Management LP 173,400$4,489,0000.51%
Newtyn Management, LLC 173,300$4,487,0000.41%
NJ State Employees Deferred Compensation Plan 38,142$988,0000.17%
King Wealth Management Group 22,500$583,0000.15%
Virtus ETF Advisers LLC 29,216$756,0000.12%
JACOBS LEVY EQUITY MANAGEMENT, INC 452,615$11,718,0000.12%
View complete list of THERAVANCE BIOPHARMA INC shareholders